Anti-Human MHCII/HLA DQ (Clone: SPVL3)

Anti-Human MHCII/HLA DQ (Clone: SPVL3)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ABE-10-4134-100 100 µg -

3 - 11 Werktage*

158,00 €
 
Protein function: Binds peptides derived from antigens that access the endocytic route of antigen... mehr
Produktinformationen "Anti-Human MHCII/HLA DQ (Clone: SPVL3)"
Protein function: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. [The UniProt Consortium]
Schlagworte: Anti-HLA-DCA, Anti-HLA-DQA1, Anti-DC-alpha, Anti-DC-1 alpha chain, Anti-MHC class II DQA1, Anti-HLA class II histocompatibility antigen, DQ alpha 1 chain, Monoclonal Antibody to Human MHCII/HLA DQ (Clone: SPVL3)
Hersteller: Abeomics
Hersteller-Nr: 10-4134

Eigenschaften

Anwendung: FC
Antikörper-Typ: Monoclonal
Klon: SPVL3
Konjugat: No
Wirt: Mouse
Reaktivität: Human
Immunogen: Cells of T4 and CTL clone HG-38 were used as immunogen for this antibody.
Format: Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Human MHCII/HLA DQ (Clone: SPVL3)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen